REFERENCES
- Chapman K R, Stockley R A, Dawkins C, Wilkes M M, Navickis R J. Augmentation therapy for α 1-antitrypsin deficiency. A meta-analysis. JCOPD 2009
- Vreim C E, Wu M, Crystal R G, Buist A S, Burrows B, Cohen A B, et al. Survival and FEV1 decline in individuals with severe deficiency of a1-antitrypsin. Am J Respir Crit Care Med 1998; 158(1)49–59
- Wencker M, Banik N, Buhl R, Seidel R, Konietzko N. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. Eur Respir J 1998; 11(2)428–433
- Charlie Strange, principal investigator, QUANTUM-1 study (QUANTitative chest computed tomography UnMasking emphysema progression in alpha-1 antitrypsin deficiency) of the NIH Rare Lung Disease Consortium, personal communication, April 13, 2009